← Back to headlines
Nuvation Bio Amends Protocol for Safusidenib Trials in Astrocytoma
Nuvation Bio Inc. has made amendments to the protocol for its Safusidenib trials, which are focused on treating astrocytoma.
2 Mar, 07:56 — 2 Mar, 07:56
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Alternative skuplje i za šest puta: Spisak lekova bez kojih ostaju pacijenti u Srbiji zbog gašenja Apoteke Beograd
7m ago
Hopes expansion plans for Rotunda can go ahead
9m ago
Τραγικός θάνατος για 73χρονο Βρετανό στη Σητεία – Όργωνε το χωράφι του και παγιδεύτηκε σε φρέζα
14m ago
India ranks second globally for children living with overweight and obesity: report
17m ago